{
    "root": "2d7b7608-a2bd-dfde-e063-6294a90afa2c",
    "code": "34391-3",
    "codeSystem": "2.16.840.1.113883.6.1",
    "displayName": "HUMAN PRESCRIPTION DRUG LABEL",
    "name": "Cimetidine",
    "value": "20250220",
    "ingredients": [
        {
            "name": "HYPROMELLOSE 2910 (6 MPA.S)",
            "code": "0WZ8WG20P6",
            "drugbank_id": "https://go.drugbank.com/drugs/DB11075"
        },
        {
            "name": "HYPROMELLOSE 2910 (50 MPA.S)",
            "code": "1IVH67816N",
            "drugbank_id": "https://go.drugbank.com/drugs/DB11075"
        },
        {
            "name": "LECITHIN, SOYBEAN",
            "code": "1DI56QDM62",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_61995"
        },
        {
            "name": "MAGNESIUM STEARATE",
            "code": "70097M6I30",
            "drugbank_id": "https://go.drugbank.com/drugs/DB14077"
        },
        {
            "name": "MICROCRYSTALLINE CELLULOSE",
            "code": "OP1R32D61U",
            "drugbank_id": "https://go.drugbank.com/drugs/DB14158"
        },
        {
            "name": "POLYDEXTROSE",
            "code": "VH2XOU12IE",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_181906"
        },
        {
            "name": "POLYETHYLENE GLYCOL 8000",
            "code": "Q662QK8M3B",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_13643"
        },
        {
            "name": "POVIDONE K30",
            "code": "U725QWY32X",
            "drugbank_id": "https://go.drugbank.com/drugs/DB14478"
        },
        {
            "name": "STARCH, CORN",
            "code": "O8232NY3SJ",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_28017"
        },
        {
            "name": "SODIUM ALGINATE",
            "code": "C269C4G2ZQ",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_53311"
        },
        {
            "name": "SODIUM STARCH GLYCOLATE TYPE A",
            "code": "H8AV0SQX4D",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_28017"
        },
        {
            "name": "SODIUM LAURYL SULFATE",
            "code": "368GB5141J",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_16189"
        },
        {
            "name": "TITANIUM DIOXIDE",
            "code": "15FIX9V2JP",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_32234"
        },
        {
            "name": "TRIACETIN",
            "code": "XHX3C3X673",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_9661"
        },
        {
            "name": "VANILLIN",
            "code": "CHI530446X",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_18346"
        },
        {
            "name": "FD&C BLUE NO. 1 ALUMINUM LAKE",
            "code": "J9EQA3S2JM"
        },
        {
            "name": "FD&C YELLOW NO. 6 ALUMINUM LAKE",
            "code": "GYP6Z2JR6Q"
        },
        {
            "name": "D&C YELLOW NO. 10 ALUMINUM LAKE",
            "code": "CQ3XH3DET6"
        },
        {
            "name": "CIMETIDINE",
            "code": "80061L1WGD",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_3699"
        }
    ],
    "indications": {
        "text": "cimetidine tablets indicated : 1. short-term treatment active duodenal ulcer.most patients heal within 4 weeks rarely reason cimetidine tablets full longer 6 weeks 8 weeks ( : duodenal ulcer ) . concomitant antacids given needed relief pain . however , simultaneous cimetidine tablets antacids recommended , since antacids reported interfere absorption cimetidine . 2. maintenance therapy duodenal ulcer patients reduced healing active ulcer.patients maintained continued treatment cimetidine tablets 400 mg bedtime periods 5 years . 3. short-term treatment active benign gastric ulcer.there information concerning usefulness treatment periods longer 8 weeks . 4. erosive gastroesophageal reflux ( gerd ) . erosive esophagitis diagnosed endoscopy . treatment indicated 12 weeks healing lesions control symptoms . cimetidine tablets beyond 12 weeks established ( : gerd ) . 5. treatment pathological hypersecretory conditions ( i.e . , zollinger-ellison syndrome , systemic mastocytosis , multiple endocrine adenomas ) .",
        "doid_entities": [
            {
                "text": "duodenal ulcer (DOID:1724)",
                "doid_id": "http://purl.obolibrary.org/obo/DOID_1724"
            },
            {
                "text": "gastric ulcer (DOID:10808)",
                "doid_id": "http://purl.obolibrary.org/obo/DOID_10808"
            },
            {
                "text": "gastroesophageal reflux (DOID:8534)",
                "doid_id": "http://purl.obolibrary.org/obo/DOID_8534"
            },
            {
                "text": "esophagitis (DOID:11963)",
                "doid_id": "http://purl.obolibrary.org/obo/DOID_11963"
            },
            {
                "text": "zollinger-ellison syndrome (DOID:0050782)",
                "doid_id": "http://purl.obolibrary.org/obo/DOID_0050782"
            },
            {
                "text": "syndrome (DOID:225)",
                "doid_id": "http://purl.obolibrary.org/obo/DOID_225"
            },
            {
                "text": "systemic mastocytosis (DOID:349)",
                "doid_id": "http://purl.obolibrary.org/obo/DOID_349"
            },
            {
                "text": "mastocytosis (DOID:350)",
                "doid_id": "http://purl.obolibrary.org/obo/DOID_350"
            },
            {
                "text": "adenomas (DOID:657)",
                "doid_id": "http://purl.obolibrary.org/obo/DOID_657"
            }
        ],
        "orphanet_entities": [
            {
                "disease": "zollinger-ellison syndrome",
                "orphanet_id": "http://www.orpha.net/ORDO/Orphanet_913"
            }
        ]
    },
    "contraindications": null,
    "warningsAndPrecautions": "cimetidine tablets , usp available containing 200 mg , 300 mg , 400 mg , 800 mg cimetidine , usp . 200 mg tablets green , film-coated , round shaped , unscored tablets debossed \u201c ci \u201d one side plain side . available follows : ndc 69452-323-20 bottles 100 tablets child-resistant closure ndc 69452-323-30 bottles 500 tablets 300 mg tablets green , film-coated , round shaped , unscored tablets debossed \u201c ci 1 \u201d one side plain side . available follows : ndc 69452-324-20 bottles 100 tablets child-resistant closure ndc 69452-324-30 bottles 500 tablets 400 mg tablets green , film-coated , round shaped tablets lip like break-line , debossed \u201c ci \u201d \u201c 2 \u201d either side score line one side plain side . available follows : ndc 69452-325-20 bottles 100 tablets child-resistant closure ndc 69452-325-30 bottles 500 tablets 800 mg tablets green , film-coated , oval shaped tablets lip like break-line one side side score line , debossed \u201c ci \u201d \u201c 3 \u201d either side score . available follows : ndc 69452-326-20 bottles 100 tablets child-resistant closure ndc 69452-326-30 bottles 500 tablets store 20\u00b0c 25\u00b0c ( 68\u00b0f 77\u00b0f ) ; excursions permitted 15\u00b0c 30\u00b0c ( 59\u00b0f 86\u00b0f ) [ usp controlled room temperature ] . protect light . dispense tight , light-resistant container defined usp using child-resistant closure . keep container tightly closed . distributed : bionpharma inc. princeton , nj 08540 made india revised : 9/2023 fda-02 948026812",
    "adverseReactions": "cimetidine tablets contraindicated patients known hypersensitivity product .",
    "indications_original": "Cimetidine tablets are indicated in:\n                  \n                     1. Short-term treatment of active duodenal ulcer.Most patients heal within 4 weeks and there is rarely reason to use cimetidine tablets at full dosage for longer than 6 weeks to 8 weeks (see\n \n  \n                        DOSAGE AND ADMINISTRATION: Duodenal Ulcer\n                     ). Concomitant antacids should be given as needed for relief of pain. However, simultaneous administration of cimetidine tablets and antacids is not recommended, since antacids have been reported to interfere with the absorption of cimetidine.\n\n \n                  \n                     2. Maintenance therapy for duodenal ulcer patients at reduced dosage after healing of active ulcer.Patients have been maintained on continued treatment with cimetidine tablets 400 mg at bedtime for periods of up to 5 years.\n\n \n                  \n                     3. Short-term treatment of active benign gastric ulcer.There is no information concerning usefulness of treatment periods of longer than 8 weeks.\n\n \n                  \n                     4. Erosive gastroesophageal reflux (GERD).Erosive esophagitis diagnosed by endoscopy. Treatment is indicated for 12 weeks for healing of lesions and control of symptoms. The use of cimetidine tablets beyond 12 weeks has not been established (see\n \n  \n                        DOSAGE AND ADMINISTRATION: GERD\n                     ).\n\n \n                  \n                     5. The treatment of pathological hypersecretory conditions(i.e., Zollinger-Ellison Syndrome, systemic mastocytosis, multiple endocrine adenomas).",
    "warningsAndPrecautions_original": "Cimetidine tablets, USP are available containing 200 mg, 300 mg, 400 mg, and 800 mg of cimetidine, USP.\n                  The 200 mg tablets are green, film-coated, round shaped, unscored tablets and debossed with \u201c\n \n  CI\u201d\u00a0on one side and plain on the other side. They are available as follows:\n\n \n                  NDC 69452-323-20\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 Bottles of 100 tablets with child-resistant closure\n                  NDC 69452-323-30\u00a0\u00a0\u00a0 \u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 Bottles of 500 tablets\n                  The 300 mg tablets are green, film-coated, round shaped, unscored tablets and debossed with \u201c\n \n  CI 1\u201d on one side and plain on the other side. They are available as follows:\n\n \n                  NDC 69452-324-20\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 Bottles of 100 tablets with child-resistant closure\n                  NDC 69452-324-30\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 Bottles of 500 tablets\n                  The 400 mg tablets are green, film-coated, round shaped tablets with lip like break-line, and debossed with \u201c\n \n  CI\u201d and \u201c\n \n  2\u201d on either side of the score line on one side and plain on other side. They are available as follows:\n\n \n                  NDC 69452-325-20\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 Bottles of 100 tablets with child-resistant closure\n                  NDC 69452-325-30\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 Bottles of 500 tablets\n                  The 800 mg tablets are green, film-coated, oval shaped tablets with lip like break-line on one side and other side score line, and debossed \u201c\n \n  CI\u201d and \u201c\n \n  3\u201d on either side of the score. They are available as follows:\n\n \n                  NDC 69452-326-20\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 Bottles of 100 tablets with child-resistant closure\n                  NDC 69452-326-30\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 Bottles of 500 tablets\n                  \n                     Store at 20\u00b0C to 25\u00b0C (68\u00b0F to 77\u00b0F); excursions permitted to 15\u00b0C to 30\u00b0C (59\u00b0F to 86\u00b0F) [See\u00a0USP Controlled Room Temperature].\n                  \n                  \n                     Protect from light.\n                  \n                  Dispense in a tight, light-resistant container as defined in the USP using a child-resistant closure.\n                  Keep container tightly closed.\n                  Distributed by: \n  \n                     Bionpharma Inc.\n                       Princeton, NJ 08540\n\n \n                  \n                     MADE IN INDIA\n                  \n                  Revised: 9/2023\n                  FDA-02\n                  948026812",
    "adverseReactions_original": "Cimetidine tablets are contraindicated for patients known to have hypersensitivity to the product.",
    "drug": [
        {
            "name": "Cimetidine",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_3699"
        }
    ]
}